Fonadelpar (SJP-0035; NPS-005) is a novel, potent, and selective PPAR δ (peroxisome proliferator
activated receptor δ) agonist with the potential for the treatment of corneal
disorders and for the research of neuroparalytic keratopathy.
纯度:≥98%
CAS:515138-06-4